Directory
>
Arjun Balar
Arjun Balar
Board Member | Volastra Therapeutics
United States
Arjun Balar
Summary
Arjun Balar is a seasoned professional in the field of oncology, currently serving as the Senior Vice President of Global Clinical Development at Loxo Oncology, part of Eli Lilly. With a comprehensive background in clinical research and drug development, his expertise spans biomarkers, clinical trials, and translational research. Arjun's academic contributions as an Associate Professor at NYU Grossman School of Medicine further solidify his commitment to advancing medical education and research. His leadership experience includes directing significant clinical programs at prestigious institutions such as NYU Langone Health and Memorial Sloan Kettering Cancer Center. Arjun's research interests focus on innovative therapies for genitourinary cancers, particularly immunotherapy and predictive biomarkers. His dual degree in Medicine and Finance provides him with a unique perspective on the intersection of healthcare and business. Arjun is passionate about improving patient outcomes through cutting-edge research and clinical excellence.
Arjun Balar
Work Experience
Board Member at
Volastra Therapeutics
April 2023 - Present
Senior Vice President - Global Clinical Development at
Loxo@Lilly
January 2023 - Present
Associate Professor Of Medicine at
New York University Real Estate Corporation
March 2018 - Present
Vice President - Global Clinical Development at
Loxo@Lilly
December 2021 - January 2023
Director - Genitourinary Medical Oncology Program at
Perlmutter Cancer Center At Nyu Langone
February 2014 - November 2021
Director - Clinical Trials Office, Perlmutter Cancer Center at
NYU Langone Health
June 2020 - November 2021
Assistant Professor Of Medicine at
Nyu Langone Medical Center
July 2012 - March 2018
Medical Oncology Fellow at
Memorial Sloan Kettering Cancer Center
July 2009 - June 2012
Residency - Internal Medicine at
NewYork-Presbyterian Hospital
July 2006 - June 2009
Arjun Balar
Education
University of South Florida College of Medicine, Md
January 2002 - January 2006
January 1998 - January 2002
Frequently Asked Questions about Arjun Balar
What is Arjun Balar email address?
Arjun Balar's primary email address is ******@volastratx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Arjun Balar work for?
Arjun Balar is a Board Member at Volastra Therapeutics, a company specializing in Commercial physical research.
Where Arjun Balar graduated from?
Arjun Balar holds a degree in Medicine from University of South Florida College of Medicine.
How can I directly contact Arjun Balar?
To contact Arjun Balar directly, you can use the email address ******@volastratx.com. Complete contact information is available upon registration with Muraena.
Who is Arjun Balar?
Arjun Balar is a seasoned professional in the field of oncology, currently serving as the Senior Vice President of Global Clinical Development at Loxo Oncology, part of Eli Lilly. With a comprehensive background in clinical research and drug development, his expertise spans biomarkers, clinical trials, and translational research. Arjun's academic contributions as an Associate Professor at NYU Grossman School of Medicine further solidify his commitment to advancing medical education and research. His leadership experience includes directing significant clinical programs at prestigious institutions such as NYU Langone Health and Memorial Sloan Kettering Cancer Center. Arjun's research interests focus on innovative therapies for genitourinary cancers, particularly immunotherapy and predictive biomarkers. His dual degree in Medicine and Finance provides him with a unique perspective on the intersection of healthcare and business. Arjun is passionate about improving patient outcomes through cutting-edge research and clinical excellence.
Arjun`s contact details
******@volastratx.com
******@loxooncology.com
***********@nyu.edu